CompletedEUCTR 2005-005343-26

Open-Label Study to Evaluate the Safety and Pharmacokinetics of Single-and Multiple-Dose Extended-Release OROS Paliperidone in Pediatric Subjects (>/= 10 to

This historical record does not confirm current site availability.

Historical research recordBelgium + FinlandSchizophrenia

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium · Finland
Study phase: Phase 1

Get this study by email

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 82
Sponsor: Janssen-Cilag International N.V.
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Drug
Study phase: Phase 1
Locations: Belgium, Finland
Age range: Not clearly listed
Official registry ID: EUCTR 2005-005343-26
Official title: Show the full official title
Open-Label Study to Evaluate the Safety and Pharmacokinetics of Single-and Multiple-Dose Extended-Release OROS Paliperidone in Pediatric Subjects (>/= 10 to

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belgium · Finland

Registry details

Historical country statuses

Belgium — Completed
Finland — Completed

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag International N.V.

Want to explore more studies?

Explore studies